Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis

Multiple sclerosis is a chronic, inflammatory, demyelinating disease of the central nervous system that most commonly affects women, with an onset typically between 20 and 40 years of age. A diagnosis of clinically definite multiple sclerosis requires the occurrence of at least two neurologic events...

Full description

Saved in:

Bibliographic Details
Published in:	The New England journal of medicine Vol. 343; no. 13; pp. 898 - 904
Main Authors:	Jacobs, Lawrence D, Beck, Roy W, Simon, Jack H, Kinkel, R. Phillip, Brownscheidle, Carol M, Murray, Thomas J, Simonian, Nancy A, Slasor, Peter J, Sandrock, Alfred W
Format:	Journal Article
Language:	English
Published:	Boston, MA Massachusetts Medical Society 28-09-2000
Subjects:	b-Interferon b1a-Interferon Biological and medical sciences Investigative techniques, diagnostic techniques (general aspects) Medical sciences Multiple sclerosis Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Nervous system Neurology Optic nerve Patients Radiodiagnosis. Nmr imagery. Nmr spectrometry Human Nervous system diseases Kaplan Meier estimator Multiple sclerosis Treatment efficiency Cytokine Central nervous system Controlled therapeutic trial Exploration Nuclear magnetic resonance imaging Intramuscular administration Inflammatory disease Randomization Treatment Demyelination Central nervous system disease Beta interferon Double blind study Medical imagery Adult Survival curve Brain (vertebrata)
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!